Abstract
The continuous infusion of a low dose of glucagon (35 μg/kg/d, for 5 d) constitutes, in view of glucose-6-phosphatase and phosphoenolpyruvate carboxykinase activities , a reliable experimental model of hyperglucagonemia. By conjunction of monooxygenase assays and immunoquantitation of specific isozymes of cytochrome P-450, the actual inducing ability of glucagon has been shown and it might explain some of the modifications of the drug metabolizing system in diabetic mice. The isozymic pattern of cytochrome P-430 of liver microsomes from diabetic mice appears very different from that produced by classical inducers.
Similar content being viewed by others
References
Rouer E & Leroux JP (1980) Biochem. Pharmacol.29, 1959–1962.
Rouer E, Mahu JL, Columellis S, Dansette P & Leroux JP (1982) Biochimie64, 961–967.
Past MR & Cook DE (1982) Biochem. Pharmacol.31, 3329–3334.
Gruppuso PA, Susa JB, Domenech M, Ja Cha C & Schwartz R (1983) Metabolism32, 911–918.
Swanson MA (1950) J. Biol. Chem.184, 647–659.
Marsac C, Augereau C, Feldman G, Wolf B, Hansen TL & Berger R (1982) Clin. Chim. Acta119, 121–127.
Kaminsky LS, Dannan GA & Guengerich FD (1984) Eur. J. Biochem.141, 141–148.
Guengerich FP, Wang P & Davidson NK (1982) Bichemistry21, 1698–1706.
Rouer E, Le Provost E & Leroux JP (1983) Biochimie65, 679–683.
Le Provost E, Flinois JP, Beaune P & Leroux JP (1981) Biochem. Biophys. Res. Commun.101, 547–554.
Guengerich FP, Dannan GA, Wright ST, Martin MV & Kaminsky LS (1982) Biochemistry21, 6019–6030.
Guengerich FP, Wang P, Mason PS & Mitchell MB (1981) Biochemistry20, 2370–2378.
Srikant CB, Freeman D, McCorkle K & Unger RH (1977) J. Biol. Chem.252, 7434–7436.
Soman V & Felig P (1978) J. Clin. Invest.61, 552–560.
Bhathena SJ, Voyles NR, Smith S & Recant L (1978) J. Clin. Invest.61, 1488–1497.
Wimhurst JM & Manchester KL (1970) Biochem. J.120, 95–103.
Wicks WD, Lewis W & McKibbin JB (1972) Biochim. Biophys. Acta264, 177–185.
Hasumura S, Endou H, Kakuno K, Hojo K & Sakai F (1983) Japan. J. Pharmacol.33, 999–1006.
Tu YY & Yang CS (1983) Cancer Res.43, 623–629.
Harrison HE & Robinson TE (1980) Horm. Met. Res.12, 556–557.
Skett P, Cochrane AR & Joels LA (1984) Acta Endocrinol.107, 506–512.
Shiverick KT & Neims AH (1979) Drug Metab. Dispos.7, 290–295.
Cheng KC & Schenkman JB (1982) J. Biol. Chem.257, 2378–2385.
Anderson S, Holmberg I & Wikvall K (1983) J. Biol. Chem.258, 6777–6781.
Kufler D & Navarro J (1976) Life Sci.18, 507–514.
Bjorkhem I & Danielsson H (1970) Eur. J. Biochem.17, 450–459.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rouer, E., Beaune, P., Augereau, C. et al. The effect of different hyperglucagonemic states on monooxygenase activities and isozymic pattern of cytochrome P-450 in mouse. Biosci Rep 5, 335–341 (1985). https://doi.org/10.1007/BF01116906
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01116906